Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Cataract surgery followed by use of contact lenses may be better solution for infants

For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several years—and an eventual lens implant—may be the better solution.

7 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

New drug is effective against superbug MRSA

"I routinely call hospitals and request their yearly antibiotic susceptibility testing data," said Washington University in St. Louis' Timothy Wencewicz. "The log might say, for example, that they've treated hundreds of patients for Acinetobacter baumanni, a bacterium brought into U.S. hospitals by soldiers wounded in the Iraq war, with 30 different antibiotics.

6 Mar 2014

Viewpoints: Obama's budget punts on entitlements; Medicaid debate rankles states

There is a lesson in this unexpected juxtaposition nevertheless: No nation can safely base its tax and spending plans on inflexible commitments. Political life, both domestic and international, is too unpredictable. Yet U.S. government spending is mostly on autopilot. The government is scheduled to lay out $3.8 trillion this fiscal year - 70 percent of which will go to mandatory-spending programs, chiefly Social Security, Medicare, Medicaid and interest on the federal debt. Mr. Obama's plan for fiscal 2015 does not change this; it would increase overall spending slightly, paying for it with selected tax increases, while shifting money among priorities here and there. But these tweaks would take place within the same 30 percent of discretionary spending that the current budget contains (3/4).

6 Mar 2014

Treating cystic fibrosis: an interview with Simon Bedson, Senior Vice President and International General Manager at Vertex

Cystic fibrosis is a rare, life-shortening genetic disease for which there is no cure. It affects more than 75,000 people worldwide. In CF, thick, sticky mucus blocks the passages in many organs, leading to a variety of symptoms. In particular, mucus builds up and clogs airways in the lungs making it easier for bacteria to grow.

5 Mar 2014

Study examines effects of pay-for-performance-reimbursing health care in China's Ningxia Province

Pay-for-performance-reimbursing health care providers based on the results they achieved with their patients as a way to improve quality and efficiency-has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact.

4 Mar 2014

Study characterizes mechanisms of pathogenesis, transmission of bacteria that cause gonorrhea

Researchers have come a step closer to understanding how gonorrhea infections are transmitted. When Neisseria gonorrhoeae, the bacteria responsible for gonorrhea, are exposed to seminal plasma, the liquid part of semen containing secretions from the male genital tract, they can more easily move and start to colonize.

4 Mar 2014

Deficient hygiene routines make it difficult to eradicate multi-resistant bacterium

A previously unknown multi-resistant bacterium has been sticking around at a Swedish University Hospital for ten years.

3 Mar 2014

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

A new methodology for rapidly measuring the level of antibiotic drug molecules in human blood serum has been developed, paving the way to applications within drug development and personalised medicine.

3 Mar 2014

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

I know how lucky I am to be a patient who happens to also work in the healthcare system. ... Initially, I had to use antibiotic drops every hour. But my insurance would only cover one three-milliliter bottle every three weeks. Each bottle not covered by insurance cost me $130. ... My own experience makes me fear that for many Americans, health insurance may not necessarily equal health care. Access and cost will still remain barriers - and can be difficult to surmount for many (Dr. Helen Ouyang, 2/24)

28 Feb 2014

Scientists discover viruses containing genes for antibiotic resistance in fossilized human feces

A team of French investigators has discovered viruses containing genes for antibiotic resistance in a fossilized fecal sample from 14th century Belgium, long before antibiotics were used in medicine.

28 Feb 2014

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Ortho Development Corporation has received FDA clearance for its patented KASM Knee Articulating Spacer Molds. KASM is a cement spacer mold intended for use in treating patients who develop an infection after undergoing total knee replacement surgery.

28 Feb 2014

Researchers develop new method for rapid detection of anthrax

Shortly following the 9/11 terror attack in 2001, letters containing anthrax spores were mailed to news outlets and government buildings killing five people and infecting 17 others.

28 Feb 2014

Astellas' isavuconazole receives QIDP designation from FDA for zygomycosis treatment

Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive mucormycosis (also known as zygomycosis), a life-threatening invasive fungal infection caused by certain emerging molds.

27 Feb 2014

Simple change in hospital laboratory reports may improve antibiotic prescribing practices

A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online.

27 Feb 2014

LA BioMed researchers awarded NIH grant to pursue new approaches for treating MRSA

With antibiotic resistant infections on the rise and a scarce pipeline of novel drugs to combat them, researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center are pursuing entirely new approaches to meet the challenge of drug-resistant infections by taming microbes rather than killing them.

27 Feb 2014

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

The Northwestern Medicine- Sinus and Allergy Center has received a grant for more than $8.4 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to help advance the understanding of chronic rhinosinusitis (CRS) and the development of new methods for its treatment over the next five years.

26 Feb 2014

iCOMOS conference to explore science behind ‘One Health’ in complex environments

The University of Minnesota will present an international conference on the science behind One Health this spring in Minneapolis.

25 Feb 2014

Scientists identify lung-damaging molecule in cystic fibrosis patients during symptom flare-ups

A molecule previously linked to lung injuries in factory workers producing microwave popcorn might play an important role in microbial infections of the lung suffered by people with cystic fibrosis (CF), according to a recent study led by San Diego State postdoctoral researcher Katrine Whiteson.

25 Feb 2014

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN (minocycline hydrochloride) Pellet-Filled Capsules.

25 Feb 2014

Antibiotic News and Research

Further Reading

Cataract surgery followed by use of contact lenses may be better solution for infants

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

New drug is effective against superbug MRSA

Viewpoints: Obama's budget punts on entitlements; Medicaid debate rankles states

Treating cystic fibrosis: an interview with Simon Bedson, Senior Vice President and International General Manager at Vertex

Study examines effects of pay-for-performance-reimbursing health care in China's Ningxia Province

Study characterizes mechanisms of pathogenesis, transmission of bacteria that cause gonorrhea

Deficient hygiene routines make it difficult to eradicate multi-resistant bacterium

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

Scientists discover viruses containing genes for antibiotic resistance in fossilized human feces

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Researchers develop new method for rapid detection of anthrax

Astellas' isavuconazole receives QIDP designation from FDA for zygomycosis treatment

Simple change in hospital laboratory reports may improve antibiotic prescribing practices

LA BioMed researchers awarded NIH grant to pursue new approaches for treating MRSA

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

iCOMOS conference to explore science behind ‘One Health’ in complex environments

Scientists identify lung-damaging molecule in cystic fibrosis patients during symptom flare-ups

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News